Laboratory Diagnostics in COVID-19: Role of Biochemistry Lab in COVID-19
Laboratory medicine plays an essential role in timely detection, diagnosis and management of diseases. During this pandemic, clinical biochemistry laboratory has played a pivotal role in management of COVID-19 disease. Biochemical analytes play a key role in assessing the severity of disease, predic...
| Published in: | NMO Journal |
|---|---|
| Main Authors: | Mithu Banerjee, Karthick Sriram |
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Subjects: | |
| Online Access: | https://journals.lww.com/10.53772/NMO.2021.15103 |
Similar Items
Are cytokines (IL-6, CRP and adiponectin) associated with bone mineral density in a young adult birth cohort?
by: Ana Maria Baptista Menezes, et al.
Published: (2018-11-01)
by: Ana Maria Baptista Menezes, et al.
Published: (2018-11-01)
The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality
by: Wolszczak-Biedrzycka B, et al.
Published: (2023-05-01)
by: Wolszczak-Biedrzycka B, et al.
Published: (2023-05-01)
Inflammation and Venous Thromboembolism in Hospitalized Patients with COVID-19
by: Angelos Liontos, et al.
Published: (2023-11-01)
by: Angelos Liontos, et al.
Published: (2023-11-01)
Characteristics and outcomes of COVID-19 in pregnant women during the COVID-19 pandemic
by: Suruchi Desai, et al.
Published: (2024-06-01)
by: Suruchi Desai, et al.
Published: (2024-06-01)
Combining Serum Interleukin-6 and other Inflammatory Biomarkers to Improve the Prediction of COVID-19 Severity
by: Mohammed El Behery, et al.
Published: (2024-10-01)
by: Mohammed El Behery, et al.
Published: (2024-10-01)
Impact of Physiotherapy on Patients Suffering from COVID-19: An Observational Study
by: Ilie Onu, et al.
Published: (2022-06-01)
by: Ilie Onu, et al.
Published: (2022-06-01)
Tocilizumab demonstrates superiority in decreasing C-reactive protein levels in hospitalized COVID-19 patients, compared to standard care treatment alone
by: Carolina Calderón-Ochoa, et al.
Published: (2024-06-01)
by: Carolina Calderón-Ochoa, et al.
Published: (2024-06-01)
Proinflammatory status of oral fluid in COVID-19
by: I. A. Borodina, et al.
Published: (2021-11-01)
by: I. A. Borodina, et al.
Published: (2021-11-01)
The Relationship of Some Biochemical Markers with Inflammatory Prognosis in COVID-19 Patients
by: Sura Zahim HUSSEIN
Published: (2022-09-01)
by: Sura Zahim HUSSEIN
Published: (2022-09-01)
Colchicine ameliorates the chronic inflammatory state in patients with chronic rheumatic valvular heart disease: a pilot study
by: Osama Rifaie, et al.
Published: (2020-07-01)
by: Osama Rifaie, et al.
Published: (2020-07-01)
Prediction of Clinical Severity of COVID‐19 Using a Combination of Heparin‐Binding Protein, Interleukin‐6, and C‐Reactive Protein: A Retrospective Study
by: Yidan Gao, et al.
Published: (2024-08-01)
by: Yidan Gao, et al.
Published: (2024-08-01)
Association between the severity of periodontitis, COVID-19, C-reactive protein and interleukin-6 levels in hospitalized patients: a case‒control study
by: Janet Moradi Haghgoo, et al.
Published: (2023-08-01)
by: Janet Moradi Haghgoo, et al.
Published: (2023-08-01)
Diagnostic Value of C-Reactive Protein and Interleukin-6 in Prevention of Negative Appendectomy
by: H Layegh, et al.
Published: (2024-03-01)
by: H Layegh, et al.
Published: (2024-03-01)
Utility of D-dimer and other biomarkers in COVID-19 patients - A prospective study in a tertiary care center
by: Indira Priyadarshini A, et al.
Published: (2022-09-01)
by: Indira Priyadarshini A, et al.
Published: (2022-09-01)
Comparison of salivary interleukin-6, interleukin-8, C - reactive protein levels and total antioxidants capacity of obese individuals with normal-weight ones
by: Safabakhsh Deniz, et al.
Published: (2022-12-01)
by: Safabakhsh Deniz, et al.
Published: (2022-12-01)
Outcome of Pregnancy in COVID19 Positive Pregnant Women: A Retrospective Observational Study
by: Shreetoma Datta, et al.
Published: (2021-08-01)
by: Shreetoma Datta, et al.
Published: (2021-08-01)
CRP, D-dimer, and Comorbidities as Potential Prognostic Factors in Critically Ill COVID-19 Patients
by: Mai salah-elden, et al.
Published: (2024-03-01)
by: Mai salah-elden, et al.
Published: (2024-03-01)
The Value of Interleukin-6 among Several Inflammatory Markers as a Predictor of Respiratory Failure in COVID-19 Patients
by: Mitsuhiro Fujino, et al.
Published: (2021-07-01)
by: Mitsuhiro Fujino, et al.
Published: (2021-07-01)
The utility of salivary CRP and IL-6 as a non-invasive measurement evaluated in patients with COVID-19 with and without diabetes [version 3; peer review: 2 approved]
by: Citra Fragrantia Theodorea, et al.
Published: (2024-01-01)
by: Citra Fragrantia Theodorea, et al.
Published: (2024-01-01)
The Diagnostic Performance of Interleukin-6 and C-Reactive Protein for Early Identification of Neonatal Sepsis
by: Belay Tessema, et al.
Published: (2020-11-01)
by: Belay Tessema, et al.
Published: (2020-11-01)
Inflammation and Vitamin C in Women with Prenatal Depression and Anxiety: Effect of Multinutrient Supplementation
by: Anitra C. Carr, et al.
Published: (2023-04-01)
by: Anitra C. Carr, et al.
Published: (2023-04-01)
Role of interleukin 6 and highly sensitive C-reactive protein in diabetic nephropathy
by: Alshabrawy M Abdelnabi, et al.
Published: (2018-01-01)
by: Alshabrawy M Abdelnabi, et al.
Published: (2018-01-01)
The Effect of High-Dose Vitamin D on Inflammatory Markers of ICU Patients with COVID-19
by: Mohammad Hossein Zamanian, et al.
Published: (2024-12-01)
by: Mohammad Hossein Zamanian, et al.
Published: (2024-12-01)
Combined coagulation and inflammation markers as predictors of venous thrombo-embolism and death in COVID-19
by: Jaja Zhu, et al.
Published: (2024-06-01)
by: Jaja Zhu, et al.
Published: (2024-06-01)
High Resolution Computed Tomography Findings of Pulmonary Fibrosis in COVID-19 Survivors and its Association with Inflammatory Markers- A Retrospective Study
by: Tarang Patel, et al.
Published: (2022-01-01)
by: Tarang Patel, et al.
Published: (2022-01-01)
Role of interleukin-6 in COVID-19 pneumonia as marker of cytokine storm and predictor of course during hospitalization: Prospective, observational study in tertiary care setting in India
by: Shital Patil, et al.
Published: (2023-05-01)
by: Shital Patil, et al.
Published: (2023-05-01)
Time-Dependent Changes of Laboratory Parameters as Independent Predictors of All-Cause Mortality in COVID-19 Patients
by: Nathaly Limon-de la Rosa, et al.
Published: (2022-04-01)
by: Nathaly Limon-de la Rosa, et al.
Published: (2022-04-01)
Role of C-Reactive protein in COVID-19 pneumonia as “A jack of all trades is a master of none!”: A single-center experience of 2000 cases
by: Shital Patil, et al.
Published: (2022-01-01)
by: Shital Patil, et al.
Published: (2022-01-01)
Interleukin-6 as the preferred prognostic factor in infection-complicated acute myeloid leukemia
by: Natalia Bujko-Wasiak, et al.
Published: (2025-08-01)
by: Natalia Bujko-Wasiak, et al.
Published: (2025-08-01)
Effect of Peroxisome Proliferator-Activated Receptor Agonists on Serum Inflammatory Markers in Diabetic Rats
by: Majid Khazaei, et al.
Published: (2014-05-01)
by: Majid Khazaei, et al.
Published: (2014-05-01)
The Role of initial and follow-up C-reactive protein titer in COVID-19 pneumonia: A single-center study of 1000 cases in a tertiary care setting in India
by: Shital Patil, et al.
Published: (2023-01-01)
by: Shital Patil, et al.
Published: (2023-01-01)
Mathematical model of aging in COVID-19
by: Jovanikić Olivera, et al.
Published: (2023-01-01)
by: Jovanikić Olivera, et al.
Published: (2023-01-01)
Interleukin-6 versus C-reactive protein as markers for early detection of bacteremia in febrile neutropenia in pediatric population
by: Manasi Gupta, et al.
Published: (2020-01-01)
by: Manasi Gupta, et al.
Published: (2020-01-01)
Fluctuations in C-reactive protein in a hepatoblastoma patient with thrombocytosis
by: Yuya Sato, et al.
Published: (2011-08-01)
by: Yuya Sato, et al.
Published: (2011-08-01)
Comparison Study of the Inflammatory Biomarkers and Cytokine Levels in COVID-19 Patients
by: Dheyaa Saleh Mahdi, et al.
Published: (2024-08-01)
by: Dheyaa Saleh Mahdi, et al.
Published: (2024-08-01)
Association of metabolic and inflammatory molecule levels and post-covid syndrome of varying severity
by: A. A. Karaseva, et al.
Published: (2025-07-01)
by: A. A. Karaseva, et al.
Published: (2025-07-01)
A retrospective evaluation of the effects of COVID-19 vaccines on the CRP, IL-6, ferritin, and D-dimer levels of patients admitted to the COVID intensive care unit
by: Yasemin Bozkurt Turan
Published: (2025-03-01)
by: Yasemin Bozkurt Turan
Published: (2025-03-01)
Role of C-reactive protein and interleukin-6 in predicting the prognosis of ICU-admitted patients with acute exacerbation of COPD
by: Tamer Abdullah Helmy, et al.
Published: (2014-10-01)
by: Tamer Abdullah Helmy, et al.
Published: (2014-10-01)
Inflammatory Biomarkers as Outcome Measures in Physiotherapy Interventions for Knee Osteoarthritis: A Systematic Review
by: Bhavna Anand, et al.
Published: (2025-04-01)
by: Bhavna Anand, et al.
Published: (2025-04-01)
Dynamic inflammatory responses guide anastomotic strategy in laparoscopic gastrectomy: a prospective cohort study
by: Zhiqiang Wang, et al.
Published: (2026-04-01)
by: Zhiqiang Wang, et al.
Published: (2026-04-01)
Similar Items
-
Are cytokines (IL-6, CRP and adiponectin) associated with bone mineral density in a young adult birth cohort?
by: Ana Maria Baptista Menezes, et al.
Published: (2018-11-01) -
The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality
by: Wolszczak-Biedrzycka B, et al.
Published: (2023-05-01) -
Inflammation and Venous Thromboembolism in Hospitalized Patients with COVID-19
by: Angelos Liontos, et al.
Published: (2023-11-01) -
Characteristics and outcomes of COVID-19 in pregnant women during the COVID-19 pandemic
by: Suruchi Desai, et al.
Published: (2024-06-01) -
Combining Serum Interleukin-6 and other Inflammatory Biomarkers to Improve the Prediction of COVID-19 Severity
by: Mohammed El Behery, et al.
Published: (2024-10-01)
